7RS-29780-78133
4 vaccinations
4 coded responses
30 check-ins
3 free-text entries
2 call cases
- Sex
- Male
- Age at first dose
- 61-65
- ZIP prefix
- 708 / LA
- Registered
- 2021-03-05
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-01
Dose 1 — Pfizer-BioNTech
-
2021-03-05
Registered in v-safe
- 2021-03-07
- 2021-03-08
- 2021-03-15
-
2021-03-22
Dose 2 — Pfizer-BioNTech
- 2021-03-22
-
2021-03-23
Survey response — days 1–6 daily, dose 2MedDRA: Injection site discolouration, Pyrexia — Feeling: GoodFree text: Slightly sore at injection site but not painful. May have had a slight increase in temperature, but not enough to feel feverish.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-24
- 2021-03-25
- 2021-03-26
- 2021-03-27
- 2021-03-28
- 2021-03-29
- 2021-04-05
- 2021-04-12
- 2021-04-19
- 2021-04-27
- 2021-05-03
- 2021-06-21
- 2021-09-20
-
2021-10-26
Dose 3 — Pfizer-BioNTech
-
2022-01-30
Survey response — 3 months, dose 3MedDRA: Cough, Fatigue, Nasopharyngitis, Night sweats, Respiratory tract congestion, SARS-CoV-2 test positive, Unevaluable event — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Symptoms: Tested positive for Covid-19 on January 21, 2021. Symptoms started the evening of January 19th, seemed like a head cold. On 20th had a cough and workplace sent me for test on 21st. Had chest congestion , and night sweats 21st, 22nd and fatigued. · Healthcare visit (other): Prescribed Tessalon 200 mg and Flovent HFA.MedDRA releases: 2024-11 · check-in free text available
-
2022-01-30
Report sent to call center — 3 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-02-01
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
-
2022-04-26
Survey response — 6 months, dose 3MedDRA: Nasopharyngitis — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Felt like a bad cold.MedDRA releases: 2024-11 · check-in free text available
-
2022-04-26
Report sent to call center — 6 months, dose 3Be unable to work or attend school · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-04-27
-
2022-04-28
Callback requested for07:00PM ET
-
2022-04-28
Call successfulCompleted over the phone
-
2022-10-20
Dose 4 — Pfizer-BioNTech
- 2022-10-26
- 2022-10-26
- 2022-10-27
- 2022-11-04
- 2022-11-10
- 2022-11-17
- 2022-11-24
- 2022-12-02
-
2023-01-20
Survey response — 3 months, dose 4MedDRA: Lower respiratory tract infection, Nasopharyngitis, SARS-CoV-2 test negative — Feeling: FairMedDRA releases: 2024-11
- 2023-04-20
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-01 | Pfizer-BioNTech | |
| 2 | 2021-03-22 | Pfizer-BioNTech | |
| 3 | 2021-10-26 | Pfizer-BioNTech | No |
| 4 | 2022-10-20 | Pfizer-BioNTech | No |
Call center
2 call center cases
2 successful
VAERS report filed, before or during a call: 1
Free text
Release 6 — days 1–6 daily, dose 2
Systemic reaction (other): Slightly sore at injection site but not painful. May have had a slight increase in temperature, but not enough to feel feverish.
Release 11 — 3 months, dose 3
Symptoms: Tested positive for Covid-19 on January 21, 2021. Symptoms started the evening of January 19th, seemed like a head cold. On 20th had a cough and workplace sent me for test on 21st. Had chest congestion , and night sweats 21st, 22nd and fatigued. cut off by CDC
Healthcare visit (other): Prescribed Tessalon 200 mg and Flovent HFA.
Release 11 — 6 months, dose 3
Symptoms: Felt like a bad cold.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Unevaluable event | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Lower respiratory tract infection | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Night sweats | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
| SRO | Injection site discolouration | ✓ | ✓ | ✓ |
| SRO | Pyrexia | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release